Searched for
PHARMA SECTOR ALLOCATION
MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...- JioBlackRock CIO Rishi Kohli decodes Nifty’s inflection point after two years of weak returnsJioBlackRock CIO Rishi Kohli says largecap valuations have de-rated, while Indian banks have underperformed global peers, creating potentia...
- Bank of India MF CIO Alok Singh sees banks poised for a re-rating. Here’s what could trigger itBank of India Mutual Fund CIO Alok Singh sees scope for banks to re-rate as low NPAs, healthy returns and loan growth support fundamentals....
- ETMarkets Smart Talk | Don’t chase growth at any valuation; rising US yields can pressure P/E multiples: Manish KumarMidcap and smallcap stocks are hitting record highs, but rising valuations and higher US Treasury yields could challenge the rally. ICICI P...
- 3 smallcap mutual funds returned over 23% in 2026. These 5 stocks feature in all their portfoliosIn 2026, three smallcap mutual funds delivered remarkable returns exceeding twenty-three percent. Notably, these outstanding funds uniforml...
- Quant Mid Cap Fund exits ICICI Bank, 2 others and adds 5 stocks in AugustQuant Mid Cap Fund exited ICICI Bank, Ambuja Cements and L&T Technology Services in August, while adding six stocks including IDBI Bank, Co...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- JioBlackRock Flexi Cap Fund exits NALCO, Hindustan Zinc; trims exposure in BSE, RILJioBlackRock Flexi Cap Fund reshuffled its portfolio in August, exiting 21 stocks while reducing exposure to 34 others, including NALCO, Hi...
- Midcap rally hides a deeper split: Every second stock down but index up 11% in 1 year. Are investors walking on thin ice?The Nifty Midcap 150 has gained around 11% over the past year, outperforming the Nifty’s 6% decline. However, the gains have been uneven, w...
- Invesco’s ₹16,000 crore midcap fund delivered 426% return in 10 years. Aditya Khemani reveals the strategyInvesco India Midcap Fund has impressively delivered a 426% return over a decade, showcasing an investment strategy that values robust earn...
- Why DSP Mutual Fund's Chirag Dagli is betting on CDMO, hospitals and smallcap healthcare stocksAt the same time, the fund is evaluating hospital expansion, hybrid diagnostics businesses and valuations to identify healthcare companies ...
- FIIs poured nearly Rs 50,000 crore into these sectors in last 2 months. Here’s what they boughtForeign investors turned net buyers in India, deploying Rs 49,830 crore across sectors in July and August, with consumer services, healthca...
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...
- FIIs are coming back: Can Indian stocks sustain buying for 3rd consecutive month in September?Foreign investors returned strongly to Indian equities, with August FPI inflows exceeding $3.2 billion. Consumer Services, Financials and H...
- Rising global bond yields, FCNR-B inflows and SEBI's CAS to shape market dynamics: HDFC Securities CEO Dhiraj RelliIndia is grappling with rising global bond yields and surging oil prices, which are heightening imported inflation. These economic challeng...
- M&A deals double, but execution holds the key for investors: Crisil RatingsIndia Inc’s annual M&A volumes have more than doubled since fiscal 2017 as companies pursue faster growth, market expansion and new capabil...
- Indian companies step up acquisitions for AI, technology and talent: CrisilThe ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...
- MF Tracker: ITI Small Cap Fund delivers 25% returns, tops 3-year chart. Should you book profits now?ITI Small Cap Fund topped the three-year return chart with a 25.19% return, outperforming its benchmark and category average. While strong ...
- Why investors should not ignore largecaps despite the smallcap rush: Canara Robeco CIO Shridatta BhandwaldarWe are looking at the next 12-18 months from a two perspective, corporate earnings growth and impact of geopolitics through higher energy p...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
Load More
